Preventing the Ebola virus
Using unorthodox, cutting-edge technologies that went against prevailing scientific opinion, Dr. Xiangguo Qiu, adjunct professor in medical microbiology at the University of Manitoba, and co-winner Dr. Gary Kobinger created ZMapp to treat patients with the Ebola virus. ZMapp comprises a cocktail of monoclonal antibody therapies that act like missiles targeting the outer shell of the Ebola virus, preventing it from replicating. Its first human applications resulted in the full recovery of two medical missionaries and 25 first responders and residents during the 2014 Ebola outbreak in Liberia. Since then, ZMapp has been driving studies into the efficacy of monoclonal antibody therapies against HIV, Lassa, Marburg and other infectious illnesses.
* Xianngguo Qiu is a 2018 co-winner of the Governor General’s Innovation Awards.